by Stefan Schuber, U.S. Pharmacopeia
Stefan Schuber
Advertisement
Articles by Stefan Schuber
Advertisement
Latest Updated Articles
- Guest Editorial: Back to the Beginning
Published: November 15th 2002 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
